Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › OH › Columbus › NPI 1588794200

Retina Group, INC

Retina Group, INC was paid $4.44M by Medicaid between Jan 2018 and Dec 2024, across 27 billing codes. Its largest line is J0178, Injection, aflibercept, 1 mg — 79% of everything it billed.

33Billing provider infoRETINA GROUP, INC
COLUMBUS, OH 43215
33aNPI1588794200assigned 03/06/2007
33bProvider typeSpecialist
28Total paid$4.44M
24GClaims70,597
24DCodes billed27
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Specialist providers in Ohio

Rank by total paid#5 of 219
Median peer was paid$46K
This provider vs. median97×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$100K$200K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
20188,600$344K
201911,063$336K
202010,927$265K
202111,810$475K
202212,748$1.02M
202310,073$1.38M
2024incomplete5,376$612K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
J0178 Injection, aflibercept, 1 mg 79% 3,090 2,522 $3.50M
67028 Intravitreal injection of a pharmacologic agent 12% 9,998 8,211 $542K
92134 3.1% 15,048 12,763 $136K
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 2.7% 4,911 4,332 $118K
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 1.2% 1,458 1,269 $54K
99204 Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity <1% 550 479 $30K
J9035 Injection, bevacizumab, 10 mg <1% 571 472 $27K
J3590 Unclassified biologics <1% 728 604 $26K
92226 <1% 431 250 $4K
92202 <1% 203 171 $1K
92012 Ophthalmological services: medical examination and evaluation, intermediate, established patient <1% 53 48 $716.12
92225 <1% 24 14 $177.56
15 more codes
2026F 0% 2,526 $0.00
G9744 Patient not eligible due to active diagnosis of hypertension 0% 4,170 $0.00
G8427 Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications 0% 5,272 $0.00
2024F 0% 2,526 $0.00
2022F 0% 2,759 $0.00
5010F 0% 1,917 $0.00
G8785 Blood pressure reading not documented, reason not given 0% 608 $0.00
4004F 0% 63 $0.00
G8397 Dilated macular or fundus exam performed, including documentation of the presence or absence of macular edema and level of severity of retinopathy 0% 1,958 $0.00
G9903 Patient screened for tobacco use and identified as a tobacco non-user 0% 5,355 $0.00
1036F 0% 6,094 $0.00
G9902 Patient screened for tobacco use and identified as a tobacco user 0% 194 $0.00
G9906 Patient identified as a tobacco user received tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling and/or pharmacotherapy) 0% 63 $0.00
G8952 Elevated or hypertensive blood pressure reading documented, indicated follow-up not documented, reason not given 0% 14 $0.00
4177F 0% 13 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialDELANEY, NICKOLE (PRACTICE ADMINISTRATOR)